Allergic reactions to the Ad26.COV2.S vaccine in South Africa
{{output}}
Background: The Janssen-Ad26.COV2.S vaccine is authorized for use in several countries, with more than 30 million doses administered. Mild and severe allergic adverse events following immunization (AEFI) have been reported. ... ...
